logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

US Mortgage Rates See Biggest One-Year Drop, Homeowner Refinancing Demand Surges

date
12/09/2025
According to the Wise Finance and Economics APP, mortgage rates in the United States have seen the largest drop in a year, leading to a significant increase in demand for refinancing among homeowners looking to save money. Fannie Mae stated in a press release that the average interest rate for a 30-year fixed-rate mortgage is 6.35%, lower than last week's 6.5%.
Latest
2 m ago
Hong Kong stocks surged | Meitu Company (01357.HK) rose more than 5%, joining hands with Tongyi Wanxiang to continue promoting the industrialization of AIGC technology in multiple fields.
2 m ago
In the first half of the year, market regulation departments have achieved significant results in cracking down on infringement and counterfeiting.
3 m ago
Gao Jianhui, former director-level inspector of the Henan Provincial Committee inspection team, is under disciplinary review and investigation by the supervisory authorities.
4 m ago
The three major indices collectively turned red.
5 m ago
Hong Kong stocks news | Pharmaron Health-B (02617.HK) rises by over 18% again, with a total market value exceeding HK$50 billion. The phase II trial of Tenofovir Alafenamide for breast cancer was approved.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.